Unlike Lean-EVs, MetS-EVs did not improve the renal mitochondrial density, area, or matrix density, did not decrease mitochondrial H202 generation, or increase COX-IV activity and ATP production. The gene discussed is COX4I1; the disease is metabolic syndrome.